Replies to post #3434 on Galectin Therapeutics Inc. (GALT)

[Amatuer17]

Maybe or not

BMY has clearly shown interest in NASH- and they were testing GRMD02 with Yervoy. They can test with Opdivo as PD-1 to get similar results. So BMY could do full BO

MERCK will need it for Ketruda - however the drug is same for both indications - so it is a buy 1 get 1 free
They can buy the co and sell rights for NASH to GILD on revenue sharing basis and recover cost of BO

[Rocketstockpix]

Galectin Therapeutics Inc (GALT:NASDAQ)
Export chart+ WATCHLIST
Real Time Quote | NASDAQ Last Sale Trades, Consolidated Volume | USD
Last | 2:58:51 PM EDT Volume 52 week range
5.8258 +0.39 (+7.09%)
567,984
1.28 - 9.49